Baseline (18)F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective Study

Post-transplant lymphoproliferative disorder (PTLD) is a rare complication of immunosuppression. Sequential treatment is commonly proposed, combining induction with rituximab (R-induction) followed by either continuation of treatment or addition of chemotherapy depending on response. Response to R-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Morland, David, Kanagaratnam, Lukshe, Hubelé, Fabrice, Toussaint, Elise, Choquet, Sylvain, Kas, Aurélie, Caquot, Pierre-Ambroise, Haioun, Corinne, Itti, Emmanuel, Leprêtre, Stéphane, Decazes, Pierre, Bijou, Fontanet, Schwartz, Paul, Jacquet, Caroline, Chauchet, Adrien, Matuszak, Julien, Kamar, Nassim, Payoux, Pierre, Durot, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875954/
https://www.ncbi.nlm.nih.gov/pubmed/36713354
http://dx.doi.org/10.1097/HS9.0000000000000833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875954/
https://www.ncbi.nlm.nih.gov/pubmed/36713354
http://dx.doi.org/10.1097/HS9.0000000000000833

Ejemplares similares